×

Healthcare's best bets following generic EpiPen

12:26 PM ET Mon, 29 Aug 2016

Amid Mylan launching an EpiPen generic alternative, the “Fast Money Halftime Report” traders and CNBC’s Jim Cramer share their take on Mylan and the biotech sector.